Case Letter

Transition From Lichen Sclerosus to Squamous Cell Carcinoma in a Single Tissue Section

Author and Disclosure Information

Practice Points

  • Lichen sclerosus has a considerable risk for malignant transformation and requires continuous follow-up in all patients.
  • Early histological detection of invasive lesions is crucial to reduce the risk for vulvar cancer.


 

References

To the Editor:
Lichen sclerosus (LS) is a chronic inflammatory disorder of unknown etiology that most commonly affects the anogenital region. Progressive sclerosis results in scarring with distortion of the normal epithelial architecture.1,2 The lifetime risk for developing squamous cell carcinoma (SCC) as a complication of long-standing LS has been estimated as 4% to 6%.3,4 However, there is no general agreement concerning the exact relationship between anogenital LS and SCC.1 The coexistence of histologic findings of LS, vulvar intraepithelial neoplasia (VIN), and SCC in the same tissue is rare. We report a case of VIN and SCC developing in a region of preexisting LS.

Figure 1. Solitary, reddish,erosive nodule on the clitorissurrounded by a pearly white,smooth, glistening area.

A 76-year-old woman presented with a 7-mm nodule on the clitoris that was surrounded by a pearly white, smooth, glistening area (Figure 1). The patient reported pain and tenderness associated with the nodule. No regional lymphadenopathy was evident. We performed an excisional biopsy of the entire nodule and a small part of the whitish patch (Figure 2A). On histologic examination, the presence of hyperkeratosis, epidermal atrophy, a swollen dermal collagen bundle, and prominent edema was consistent with LS (Figure 2B). The presence of dysplastic changes with mild disturbance of the epithelial architecture as well as acanthosis and dyskeratosis in the same tissue confirmed VIN (Figure 2C). Dermal invasion and transition to SCC were seen in the part of the tissue verified as VIN. The presence of dermal tumor nests and an irregular border between the epidermis and dermis pointed to the existence of fully developed SCC (Figure 2D). To prevent the recurrence of SCC, the patient returned for follow-up periodically. There was no recurrence within 6 months after excision.

Figure 2. An excisional biopsy showed epidermal thinning on the left side and invasion of the dermis by a tumor nest on the right side (A)(H&E, original magnification ×10). Left, center, and right boxes indicate areas shown in Figures 2B, 2C and 2D, respectively. Hyperkeratosis, epidermal atrophy, a swollen dermal collagen bundle, and prominent edema was evident (B)(H&E, original magnification ×200). Dysplactic changes with mild disturbance of the epithelial architecture accompanied by acanthosis and nuclear atypia were seen (C)(H&E, original magnification ×200). Irregular masses of atypical squamous cells spread downward into the dermis representing squamous cell carcinoma of a well-differentiated type (D)(H&E, original magnification ×200).

Although LS is considered a premalignant condition, only a small portion of patients with LS ultimately develop vulvar SCC.5 There are a number of reasons for linking LS with the development of vulvar SCC. First, in the majority of cases of vulvar SCC, LS, squamous cell hyperplasia, or VIN is present in the adjacent epithelium. Lichen sclerosus is found in adjacent regions in up to 62% of vulvar SCC cases.6 Second, patients with LS may develop vulvar SCC, as frequently reported. Third, in a series of LS patients who underwent long-term follow-up, 4% to 6% were reported to have developed vulvar SCC.3,4,7

Lichen sclerosus is an inflammatory dermatosis characterized by clinicopathologic persistence and hypocellular fibrosis.2 Changes in the local environment of the keratinocyte, including chronic inflammation and sclerosis, may be responsible for the promotion of carcinogenesis.8 However, no molecular markers have been proven to identify the LS lesions that are at risk for developing into vulvar SCC.9,10 It has been suggested that VIN is the direct precursor of vulvar SCC.11,12

Histologic diagnosis of VIN is difficult. Its identification is hindered by a high degree of cellular differentiation combined with the absence of widespread architectural disorder, nuclear pleomorphism, and diffuse nuclear atypia.13 The atypia in VIN lesions is strictly confined to the basal and parabasal layers of the epithelium.11 Vulvar intraepithelial neoplasia has seldom been diagnosed as a solitary lesion because it appears to have a short intraepithelial lifetime.

Vulvar SCC can be divided into 2 patterns. The first is found in older women, which is unrelated to human papillomavirus (HPV). This type occurs in a background of LS and/or differentiated VIN. The second is predominantly found in younger women, which is related to high-risk HPV. This type of vulvar SCC frequently is associated with the histologic subtypes of warty and basaloid differentiations and is referred to as undifferentiated VIN. There is no association with LS in these cases.2,14,15

It has been suggested that LS and HPV may not be mutually exclusive but may act as cofactors in SCC pathogenesis.16 Infection with HPV is an early event in the multistep process of vulvar carcinogenesis, and HPV integration into host cell genome seems to be related to the progression of vulvar dysplasia.17 Viral integration generally disrupts the E2 region, resulting in enhanced expression of E6 and E7. E6 and E7 have the ability to bind and inactivate the protein p53 and retinoblastoma protein, which promotes rapid progression through the cell cycle without p53-mediated control of DNA integrity.18 However, the exact influence of HPV in vulvar SCC is uncertain, as divergent prevalence rates have been published.

Pages

Recommended Reading

EADV: Vismodegib treatment breaks don’t hurt efficacy
MDedge Dermatology
Sirolimus reduced posttransplant skin cancer risk
MDedge Dermatology
Organ transplant recipients face increased risk of BCC
MDedge Dermatology
Average person with atopic dermatitis has no increased risk of actinic keratosis or nonmelanoma skin cancer
MDedge Dermatology
When the Doctor Is Not a Doctor
MDedge Dermatology
Itraconazole targets basal cell carcinoma
MDedge Dermatology
Poor Sun Protection Practices in Hispanic Patients Increases Risk for Skin Cancer
MDedge Dermatology
Nicotinamide Prevents Actinic Keratoses, Basal Cell Carcinomas, and Squamous Cell Carcinomas
MDedge Dermatology
Tools for Diagnosing Skin Cancer Earlier: Report From the AAD Meeting
MDedge Dermatology
Intralesional interferon excels for challenging basal cell carcinomas
MDedge Dermatology